Charleston, SC -- (SBWIRE) -- 10/02/2013 -- The Team of advisers at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer. Have a look at: Unseen Solar, Inc. (OTCMKTS:PCWT), Eco Building Products Inc (OTCMKTS:ECOB), Intellect Neurosciences, Inc. (OTCMKTS:ILNS), Biozone Pharmaceuticals Inc (OTCBB:BZNE)
Unseen Solar, Inc. (OTCMKTS:PCWT) decreased -13.18% and closed at $0.218 on a traded volume of 6.14 million shares, in comparison to 6.07 million shares of average trading volume. So far this year, the stock is down over -27.33%.
The company has a total market capitalization of $225.90 million. Pacific Clean Water Technologies Inc. engages in the provision and operation of on-site chemical and non-chemical water treatment programs for the treatment of boilers, cooling systems, and process systems in the southwestern United States.
Has PCWT Found The Bottom and Ready To Move Up? Find Out Here
Eco Building Products Inc (OTCMKTS:ECOB) soared +1.00% and closed at $0.0101 on a traded volume of 5.90 million shares, whereas its average trading volume is 4.63 million shares. In the last three months, the stock is down -40.59%. The Intra-day range for the stock is $0.01 and $0.011.
Eco Building Products, Inc. engages in the manufacture and sale of wood coatings for framing lumber and other wood products used in the construction of single-family homes and multi-story buildings.
Will ECOB Continue To Move Higher? Find Out Here
Intellect Neurosciences, Inc. (OTCMKTS:ILNS) jumped up +11.76% and closed at $0.0095. So far in three months, the stock is up +90.00%. The 52-week range for the stock is $0.0047 and $0.135 and during the previous trading session the stock touched its highest price at $0.0095. Its introductory price for the day was $0.0085, with the overall traded volume of 5.70 million shares.
Intellect Neurosciences, Inc., a biopharmaceutical company, discovers and develops therapeutic agents for the treatment and prevention of proteinopathies, which include Alzheimer’s, Parkinson’s, and Huntington diseases.
For How Long ILNS will Fight for Profitability? Read This Trend Analysis report
Biozone Pharmaceuticals Inc (OTCBB:BZNE), after opening its shares at the price of $0.61, dropped -4.24% to close at $0.565 for the day. The stock moved on a traded volume of 5.47 million shares, in comparison to 268,311 shares of average trading volume.
The 52-week range for the stock is $0.16 and $3.75 and during the previous trading session the stock touched its highest price at $0.61. Its introductory price for the day was $0.61. Biozone Pharmaceuticals, Inc., through its subsidiaries, engages in developing and manufacturing over the counter (OTC) drug products, and cosmetic and beauty products on behalf of third parties in the United States and internationally.
Why Should Investors Buy BZNE After the Recent Fall? Just Go Here and Find Out
Our team of advisers here at Capital Equity Report are committed to bringing you stock picks that are noteworthy and priced at a great value. We work for you and we welcome any feedback you may have to offer.
The disclaimer is to be read and fully understood before using our site, or joining our newsletter email list. Never invest into a stock discussed on this web site or the CapitalEquityReport.com newsletter unless you can afford to lose your entire investment.
Please consult with a certified financial advisor before making any investment decisions.
Read Full Disclaimer at: http://capitalequityreport.com/about-us/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)